Dr. Ling Zhu

Dr. Ling Zhu obtained his Ph.D. from the Department of Biochemistry, Rutgers (USA) in 2008 and joined the Macula Research Group in Save Sight Institute to continue his career at the interface of clinical and basic research. He is now the head of the lab unit leading one postdoc, two research assistants, and one HDR student. He has established a diverse array of techniques, which have greatly facilitated several projects in studying the cellular and molecular pathogenesis of debilitating retinal diseases such as diabetic retinopathy, age-related macular degeneration, and macular telangiectasia type 2. He successfully attracted more than 2M dollars of research funding in the past five years. Dr. Zhu has broad knowledge and well-established skills in Biochemistry and Molecular biology. He has established human retinal explants, which is the unique ex vivo model required in the proposed study. He has a career total of 93 publications, 40 within the past five years, with 3590 citations, H-index 34 (14 years post-PhD). He is the major author of most of these papers published in the leading journals in the field, such as eLife and Ophthalmology.